Retinol Binding Protein 4 Antibody / RBP4 Monoclonal antibody

Name: Retinol Binding Protein 4 Antibody / RBP4 Monoclonal antibody
Brand: Auker Biotech Co., Ltd.
SKU: 1931251131

Hubei, ChinaAuker Biotech Co., Ltd.

US$300.00

1-99 mg

US$160.00

100-999 mg

US$60.00

1,000+ mg

Sample price:US$100.00/mg.Request sample

Product profile

Customization

Available

Supply Type

OBM(Original Brand Manufacturing)

Usage Mode

For external use

Model NO.

antibody

Suitable for

Elderly, Adult

Type

Antibody, Antigen

Application

for Diagnosis

Form

Liquid

Storage

2-8 degrees

Shelf life

2 years

Purity

96%

Delivery time

3-5 days

Usage

Elisa kit

Transport Package

Bottle

Specification

1mg/bottle

Trademark

Aoke Botai

Origin

China

HS Code

3002130090

Production Capacity

10g/Month

Company profile

Auker Biotech Co., Ltd.

Hubei, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2020-04-30Nearest Port: Wuhan, ShanghaiAverage Response Time: ≤15hTerms of Payment: T/T, PayPal, Western UnionInternational Commercial Terms(Incoterms): FOB, EXW, CIF

AI-Powered supplier vetting

SummaryAuker Biotech Co., Ltd. is a China-based limited company and factory/trading company located in Wuhan, Hubei. It specializes in in-vitro diagnostic raw materials, including antigens, antibodies, recombinant proteins, and related customized services. The supplier reports ISO 9001 and ISO 13485 certifications, two technology platforms, three production lines, dedicated R&D and quality-control personnel, and export activity across multiple global regions. It has self-operated import/export rights and reports order fulfillment within 15 working days in both peak and off-peak periods. Evidence supports established technical, certification, production, and export capabilities. However, the provided information does not sufficiently establish after-sales service practices, financial credibility, or verified customer case depth. The trade record shows only two transactions and one associated buyer name, so customer experience evidence remains limited.

Supplier typeThe supplier is identified as a factory, manufacturer/trading company, and limited company based in Wuhan, China. Its stated business focuses on R&D, production, and sales of in-vitro diagnostic raw materials, including antigens, antibodies, and recombinant proteins.

CertificationsThe supplier reports ISO 9001 and ISO 13485 quality system certifications. These certifications provide explicit evidence of formal quality-management and medical-device-related management systems.

R&D capabilityThe company states that it was established in 2002, operates a mouse monoclonal antibody hybridoma platform and a recombinant protein expression platform, and is recognized as a high-tech enterprise with several innovation-related honors. These details explicitly support established R&D and innovation capability.

Production capacityThe supplier reports production of in-vitro diagnostic raw materials, three production lines, operation of a colloidal gold and fluorescence chromatography large-plate production line since 2021, and order fulfillment within 15 working days in both peak and off-peak seasons. This supports active and reasonably responsive production capability.

Customization capabilityThe company explicitly states that it provides customized services for monoclonal antibodies, multi-antibodies, and recombinant proteins. This is direct evidence of customization capability in its core product categories.